What is the P/E ratio of Dosch Pharmaceuticals Pvt . (Amalgamated)?

The latest standalone P/E ratio of Dosch Pharmaceuticals Pvt . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Dosch Pharmaceuticals Pvt . (Amalgamated)?

The latest standalone P/B ratio of Dosch Pharmaceuticals Pvt . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Dosch Pharmaceuticals Pvt . (Amalgamated)?

The 52-week high of Dosch Pharmaceuticals Pvt . (Amalgamated) is Rs. and the 52-week low is Rs. .

Dosch Pharmaceuticals Pvt Ltd. (Amalgamated) - Stock Valuation and Financial Performance

Name: Dosch Pharmaceuticals Pvt . (Amalgamated)
Brand: Dosch Pharmaceuticals Pvt . (Amalgamated)

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Dosch Pharmaceutical

Based on:

Data

M-Cap below 100cr DeciZen not available

Dosch Pharmaceuticals Pvt Ltd. (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Dosch Pharmaceutical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
ROCE % ⓘ	10.1%	15.4%	-3.9%	-30.2%	206.9%	2.3%	-0%	-1.8%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	48.2	60	78.6	31.7	26.7	22.6	24.4	31.9	32
Sales YoY Gr.	-	24.4%	31%	-59.7%	-15.6%	-15.6%	8.2%	30.9%	-
Adj EPS ⓘ	52.4	84.2	-156.3	-1,271.1	7,027	125.2	-24.6	-206.2	0
YoY Gr.	-	60.6%	-285.7%	NA	NA	-98.2%	-119.6%	NA	-
BVPS (₹) ⓘ	209.2	293.3	136.8	-1,177.4	5,855	5,951.3	7,843.4	7,658.4	0
Adj Net Profit ⓘ	1.1	1.8	-3.8	-31.2	172	3.1	-0.5	-3.8	0
Cash Flow from Ops. ⓘ	0	0	0	0	-79.1	0.8	44.6	-39.3	-
Debt/CF from Ops. ⓘ	0	0	0	0	-0	1	0	-0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-16.5%	6.1%	30.9%
Adj EPS ⓘ	NA	NA	-130.8%	NA
BVPSⓘ	NA	123.7%	9.4%	-2.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
Return on Equity % ⓘ	20.4	28.2	-72.7	244.3	300.5	2.1	-0.3	-2.7	0
Op. Profit Mgn % ⓘ	5.4	7.9	-4.5	-59	-4.6	-5.8	-1.8	-2.5	NAN
Net Profit Mgn % ⓘ	2.3	3	-4.9	-98.4	644.7	13.6	-1.9	-12	0
Debt to Equity ⓘ	2.4	1.9	32.3	-2.1	0	0	0	0	-
Working Cap Days ⓘ	0	168	181	295	112	163	130	115	0
Cash Conv. Cycle ⓘ	0	-9,663	105	129	-13	54	12	-19	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Dosch Pharmaceuticals Pvt Ltd. (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	31.9	-
BVPS (₹.) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	140	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	100
Industry PE ⓘ	48.8

Management X-Ray of Dosch Pharmaceutical:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Dosch Pharmaceutical

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Dosch Pharmaceutical

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Sales	48.22	59.96	78.57	31.68	26.73	22.56	24.41	31.94
Operating Expenses ⓘ	45.61	55.23	82.11	51.90	27.96	23.86	24.85	32.73
Manufacturing Costs	0	0	0	0	0	0	0	0
Material Costs	-3.93	-0.73	41.81	32.01	22.98	19.02	20.77	28.39
Employee Cost	0	0	10.94	2.98	0.74	0.78	0.83	0.38
Other Costs ⓘ	49.54	55.96	29.37	16.90	4.24	4.06	3.24	3.96
Operating Profit ⓘ	2.60	4.73	-3.54	-20.21	-1.23	-1.30	-0.44	-0.79
Operating Profit Margin (%)	5.4%	7.9%	-4.5%	-63.8%	-4.6%	-5.8%	-1.8%	-2.5%
Other Income ⓘ	0	0	0.04	1.45	193.75	5.50	8.08	8.52
Interest ⓘ	0.73	1.32	1.84	13.36	16.22	0.35	0.61	1.75
Depreciation ⓘ	0.31	0.29	0.25	0.17	0.27	0.33	6.27	7.45
Exceptional Items ⓘ	0	0	0	0	0	-1.21	0	0
Profit Before Tax ⓘ	1.56	3.12	-5.59	-32.29	176.02	2.30	0.76	-1.48
Tax ⓘ	0.46	1.34	-1.76	-0.06	3.36	0	0.82	1.95
Profit After Tax	1.11	1.78	-3.84	-32.23	172.66	2.30	-0.06	-3.43
PAT Margin (%)	2.3%	3.0%	-4.9%	-101.0%	646.0%	10.2%	-0.3%	-10.7%
Adjusted EPS (₹)	52.4	84.2	-156.0	-1,314.2	7,040.6	93.6	-3.3	-184.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Equity and Liabilities
Shareholders Fund	4.42	6.19	3.36	-28.87	143.58	145.94	145.29	141.87
Share Capital ⓘ	2.11	2.11	2.45	2.45	2.45	2.45	1.86	1.86
Reserves ⓘ	2.30	4.08	0.90	-31.32	141.13	143.49	143.43	140.01
Minority Interest	0	0	0	0	0	0	0	0
Debt	10.44	11.58	106.83	60.93	0.70	0.53	0.47	0.51
Long Term Debt	1.94	1.60	4.78	0.75	0.70	0.53	0.47	0.51
Short Term Debt	8.50	9.99	102.05	60.17	0	0	0	0
Trade Payables	6.57	9.28	15.11	7.47	2.44	3.77	3.18	5.54
Others Liabilities ⓘ	4.13	7.22	12.55	4.02	0.37	-1.80	44.38	7.48
Total Liabilities ⓘ	25.55	34.27	137.84	43.55	147.09	148.44	193.32	155.39
Fixed Assets
Gross Block	2.27	2.42	2.49	1.72	2.55	2.50	38.87	38.95
Accumulated Depreciation	0.96	1.25	1.48	1.23	1.50	1.82	8.10	15.51
Net Fixed Assetsⓘ	1.30	1.17	1	0.49	1.06	0.67	30.77	23.44
CWIP ⓘ	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	90	37.36	131.42	137.34	152.14	118.57
Inventories	7.82	9.94	9.27	1.32	0.18	1.62	1.55	1.79
Trade Receivables	13.08	19	32.63	0.22	6.76	4	0.09	0.35
Cash Equivalents	1	1.27	0.68	0.72	3.16	1.77	1.64	2.04
Others Assetsⓘ	2.35	2.89	4.27	3.44	4.50	3.05	7.13	9.19
Total Assets ⓘ	25.55	34.27	137.84	43.55	147.09	148.44	193.32	155.39

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18
Cash Flow From Operating Activity ⓘ	-79.12	0.77	44.60	-39.29
PBT ⓘ	176.02	3.51	0.76	-1.48
Adjustment ⓘ	-179.81	-4.69	-0.83	1.24
Changes in Working Capital ⓘ	-75.19	1.95	44.66	-39.06
Tax Paid ⓘ	-0.14	0	0	0
Cash Flow From Investing Activity ⓘ	97.37	-1.74	-44.61	40.85
Capex	-0.94	0.02	-51.17	33.44
Net Investments	-64.14	-5.30	2.14	4.60
Others ⓘ	162.45	3.53	4.42	2.80
Cash Flow From Financing Activityⓘ	-16.28	-0.52	-0.67	-1.71
Net Proceeds from Shares ⓘ	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.06	-0.17	-0.06	0.04
Interest Paid ⓘ	-16.22	-0.35	-0.61	-1.75
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	0	0	0	0
Net Cash Flow ⓘ	1.96	-1.50	-0.69	-0.16

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Ratios
ROE (%)	25.06	33.5	-80.38	N/A	301.03	1.59	-0.04	-2.39
ROCE (%)	14.28	25.29	-5.74	N/A	216.52	1.82	0.94	0.19
Asset Turnover Ratio	1.89	2	0.91	0.35	0.28	0.15	0.14	0.18
PAT to CFO Conversion(x)	0	0	N/A	N/A	0.26	-17.08	N/A	N/A
Working Capital Days
Receivable Days	99	98	120	189	48	87	31	3
Inventory Days	59	54	45	61	10	15	24	19
Payable Days	-610	-3,954	106	129	79	60	61	56

Dosch Pharmaceuticals Pvt Ltd. (Amalgamated) Stock News

Dosch Pharmaceuticals Pvt Ltd. (Amalgamated) FAQs

What is the share price of Dosch Pharmaceutical?

Company share prices are keep on changing according to the market conditions. The closing price of Dosch Pharmaceutical on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Dosch Pharmaceutical?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Dosch Pharmaceutical stood at ₹0.00.